Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Clinical trial NCT00061022 · COMPLETED

Trial details

NCT number: NCT00061022
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cerebral Stroke Stroke, Acute Cerebrovascular Stroke Ischemic Attack, Transient

Start date: 2003-05-01
Primary completion: 2006-09-01
Enrollment: 3200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.